Spravato® (Esketamine) Treatment in Atlanta, GA

Transform Your Life with SPRAVATO® in the Greater Atlanta Area

At Empower Psychiatry & Sleep, we are committed to offering innovative treatments for people suffering from depression and suicidal thoughts. One of our key treatments is SPRAVATO®, an FDA-approved nasal spray that has been proven to help with these conditions.

SPRAVATO® contains esketamine, which targets a specific receptor in the brain called the NMDA receptor. Studies have shown that SPRAVATO® can reduce symptoms of depression and suicidal ideation, especially in patients who have not found relief from other treatments.

We believe SPRAVATO® has the potential to make a real difference in the lives of people struggling with Difficult to Treat Depression (Treatment-Resistant Depression). Most insurance plans cover SPRAVATO®, and we are dedicated to providing the best care possible.

Real people: Watch how Spravato helped

Nicole’s Story

Sally’s Story

spravato nose spray

What Is SPRAVATO®?

SPRAVATO® is an innovative, FDA-approved treatment that has helped thousands of individuals suffering from Difficult to Treat Depression (Treatment-Resistant Depression). Unlike traditional antidepressants that can take weeks to work, SPRAVATO® may offer relief within hours. It is administered as a nasal spray under the supervision of a certified healthcare provider.

While typical antidepressants like Prozac or Zoloft work by increasing serotonin in the brain, SPRAVATO® targets the NMDA receptor, helping to reset brain cell connections. SPRAVATO® underwent rigorous trials before being approved for use in Difficult to Treat Depression (Treatment-Resistant Depression).

Difficult to Treat Depression (Treatment-Resistant Depression) and SPRAVATO®

Major depressive disorder affects millions of people worldwide, yet for an estimated one in three adults with depression, standard antidepressant medications do not provide adequate relief. This is known as treatment-resistant depression and it is the patient population SPRAVATO® was specifically developed to serve.

As a REMS-certified provider, Empower Psychiatry & Sleep LLC is authorized to administer esketamine therapy to patients with treatment-resistant depression and to those experiencing major depressive disorder with active suicidal ideation. If you have tried two or more antidepressant medications without sufficient improvement, a consultation with Dr. Singareddy can help determine whether SPRAVATO® is an appropriate next step in your care.

Psychiatric Evaluation

Spravato Treatment in Atlanta – A Breakthrough for Depression

For adults living with treatment-resistant depression who have not found adequate relief from two or more antidepressant medications, Spravato treatment Atlanta patients can access at Empower Psychiatry & Sleep LLC represents a meaningful clinical advance. As a REMS-certified provider in Suwanee, GA, our practice is one of a limited number of outpatient clinics in the North Atlanta region authorized to administer esketamine therapy Atlanta patients with treatment-resistant depression can receive under direct medical supervision.

Unlike traditional antidepressants, which can take weeks to produce noticeable effect, SPRAVATO® acts on the NMDA receptor, a mechanism distinct from serotonin-based medications and many patients report improvement in depressive symptoms within the first few sessions. If you have been searching for Spravato treatment near me, our Suwanee clinic serves patients from Alpharetta, Johns Creek, Duluth, Cumming, Milton, Buford, and across the North Atlanta region.

Benefits of Choosing Spravato Treatment Atlanta

Choosing Empower Psychiatry for Spravato treatment near me means working with a board-certified psychiatrist, Dr. Ravi Singareddy, with over 20 years of experience and Emory Healthcare Network affiliation. Our practice combines esketamine therapy Atlanta patients trust with comprehensive psychiatric care, meaning Spravato is never administered in isolation but always as part of a structured, individualized treatment plan. We accept most major insurance plans and Medicare for patients who meet clinical criteria, and our team manages prior authorization on your behalf. For those ready to explore Spravato treatment Atlanta has available through our clinic, call (770) 615-0226 or complete the interest form below.

two males chatting at a table

Preparing for your Spravato Session

Preparation is key to making the most of your SPRAVATO® treatment. Arriving at the clinic with a positive mindset and completing the necessary prep work will set you up for success. A good way to get ready is to bring something relaxing, like a book, tablet, or music. A playlist of calming music can help you get into the right mindset. Before your session, be open with yourself about your goals, and set clear intentions for what you hope to achieve.

Before Your Session: What to Know.

To maximize the effectiveness of your SPRAVATO® session, follow these helpful tips:

  • Get a full night’s rest before treatment.
  • Set your intentions for the session.
  • Inform your healthcare provider about any medications you’ve taken prior to your SPRAVATO® treatment.
  • Avoid eating for two hours before the session.
  • Refrain from drinking any liquids 30 minutes before treatment.
  • If you use nasal corticosteroids or decongestants, take them at least one hour before your SPRAVATO® session.
two women laughing on park bench

How is SPRAVATO® Administered

SPRAVATO® is a nasal spray, much like common nasal decongestants, making it simple and comfortable to use. There are no needles or IVs involved. You will self-administer the SPRAVATO® spray while a healthcare professional is there to support you. Before you begin, your healthcare provider will guide you on how to use the device correctly and will be available throughout the session to assist you as needed.

Post-Session Care

After your SPRAVATO® treatment, you will stay at the clinic for at least two hours of observation. This time allows healthcare workers to ensure you don’t experience any side effects and gives you the chance to relax, reflect on the session, and prepare to leave. Your healthcare provider will discuss future treatments with you and help you decide the next steps in your treatment plan.

Safety & Side Effects

SPRAVATO® has been thoroughly tested in both short- and long-term clinical trials, proving its safety for adults with Difficult to Treat Depression (Treatment-Resistant Depression). While SPRAVATO® is generally well-tolerated, some side effects like sleepiness, dizziness, anxiety, or a feeling of disconnection (dissociation) may occur. These effects are usually mild and fade away the same day after treatment.

REMS-Certified Spravato® Provider

SPRAVATO® is available only through a restricted FDA program known as REMS — Risk Evaluation and Mitigation Strategy — due to the potential risks of sedation, dissociation, and misuse associated with esketamine. Empower Psychiatry & Sleep LLC is fully certified under this program and meets all requirements for safe administration.

In practice, this means every patient is formally enrolled in the REMS program before treatment begins. Each session takes place exclusively at our clinic, where SPRAVATO® is self-administered under the direct observation of Dr. Singareddy or a qualified clinical team member. Following your session, you are monitored at the clinic for a minimum of two hours before being cleared to leave. Because of the temporary effects esketamine may produce, patients may not drive themselves home — please arrange transport with a responsible adult for every session.

These protocols exist to protect your safety and are a standard part of every SPRAVATO® treatment program at any certified provider. Our team will walk you through all requirements in detail before your first session.

Ravi singard

Frequently Asked Questions

SPRAVATO® is FDA-approved for two specific indications: adults with treatment-resistant depression (TRD) defined as inadequate response to at least two antidepressant medications and adults with major depressive disorder with active suicidal ideation or behavior. During your psychiatric evaluation, Dr. Singareddy or one of our providers will review your treatment history and confirm whether you meet the clinical criteria for Spravato. Not all patients with depression are candidates, and a thorough evaluation is the appropriate first step.

While both Spravato (esketamine) and intravenous ketamine target the NMDA receptor, there are meaningful differences. Spravato is FDA-approved specifically for treatment-resistant depression and MDD with suicidal ideation, is administered as a self-administered nasal spray under supervision, and is covered by most major insurance plans when clinical criteria are met. IV ketamine infusions are not FDA-approved for depression and are typically not covered by insurance. Esketamine therapy Atlanta patients receive at our REMS-certified clinic follows a structured, insurance-eligible protocol that IV ketamine does not.

Yes — most major health insurance plans and Medicare cover SPRAVATO® when clinical criteria are met, which typically requires documented inadequate response to at least two antidepressant medications. Our team verifies your benefits and manages prior authorization before your first session. The multi-step interest form on this page helps us gather the information needed to begin that process quickly. Call (770) 615-0226 to confirm your plan’s specific coverage.

Each Spravato session takes place at our Suwanee clinic under direct medical supervision. You self-administer the nasal spray while Dr. Singareddy or a team member monitors you throughout the session. Afterward, you remain at the clinic for a minimum of two hours of observation. You may not drive following a session — a responsible adult must arrange your transport. Sessions are typically scheduled twice weekly for the first month, then reduced in frequency as your treatment progresses. Plan for approximately three hours total for each visit.

One of the distinguishing features of SPRAVATO® is its potential for faster onset compared to traditional antidepressants. Some patients report improvement in depressive symptoms within the first few sessions, though individual responses vary and results are not guaranteed. Full clinical benefit is typically assessed after a complete initial treatment course. Dr. Singareddy or one of our providers will monitor your response throughout and adjust your care plan accordingly. As with any treatment for depression, realistic expectations and ongoing communication with your provider are essential.

Inquire About Spravato Treatment

Complete this form so we can assist with your mental health journey.

Step 1 of 8

Answer These Three Questions.

1. Have you been diagnosed with: (Mark all that apply) *